These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3889253)

  • 21. Combination antibiotic therapy in pediatrics.
    Chadwick EG; Yogev R; Shulman ST
    Am J Med; 1986 Jun; 80(6B):166-71. PubMed ID: 3728528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of choice for the empiric treatment of the febrile neutropenic patient.
    Barriere SL
    Drug Intell Clin Pharm; 1986 Oct; 20(10):767-9. PubMed ID: 3769764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
    Pizzo PA
    J Hosp Infect; 1990 Apr; 15 Suppl A():41-8. PubMed ID: 1971644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fever and neutropenia during intensive chemotherapy.
    Klastersky J
    Ann Oncol; 1993 Aug; 4(7):603-6. PubMed ID: 8363991
    [No Abstract]   [Full Text] [Related]  

  • 25. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
    Viscoli C; Bruzzi P; Glauser M
    Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
    Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
    Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
    Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergy. Should it determine antibiotic selection in neutropenic patients?
    Bodey GP
    Arch Intern Med; 1985 Nov; 145(11):1964-6. PubMed ID: 4062443
    [No Abstract]   [Full Text] [Related]  

  • 33. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.
    Wade JC
    Rev Infect Dis; 1989; 11 Suppl 7():S1572-81. PubMed ID: 2690295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutropenia and fever.
    Hughes WT
    Pediatr Infect Dis; 1983; 2(3 Suppl):S14-7. PubMed ID: 6866796
    [No Abstract]   [Full Text] [Related]  

  • 36. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
    Cometta A; Glauser MP
    J Chemother; 1996 Oct; 8(5):375-81. PubMed ID: 8957718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.
    Pater JL; Weir L
    J Clin Oncol; 1986 Mar; 4(3):346-52. PubMed ID: 3512784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
    Shenep JL
    NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timentin (ticarcillin and clavulanic acid) in combination with aminoglycosides in the treatment of febrile episodes in neutropenic children.
    Schaison G; Reinert P; Leverger G; Leauté JB
    J Antimicrob Chemother; 1986 May; 17 Suppl C():177-81. PubMed ID: 3722043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.